Dr. Preston C. Sprenkle specializes in the treatment of urologic cancers, including prostate cancer, kidney cancer, bladder cancer, testicular cancer and sarcoma – a rare kind of cancer that grows in cells that connect or support other parts of the body, like bone or muscle.
Dr. Sprenkle has dedicated his career to using the latest imaging technologies to improve diagnosis. He was one of the first physicians nationwide to implement the use of the Artemis Device. This machine, introduced in 2009, allows a surgeon to use 3D ultrasound technology and merge it with even more precise magnetic resonance imaging (MRI) to accurately identify cancerous tumors.
“Skilled and experienced radiologists are rare for this relatively new technique,” Dr. Sprenkle explains. “At Yale, we are fortunate to have some of the world leaders in prostate MRI.”
Dr. Sprenkle is also a pioneer in “focal therapy,” which allows a surgeon to treat tiny prostate lesions, rather than the whole organ. This avoids many of the side effects—such as erectile dysfunction and incontinence—that may follow the removal of the whole prostate.
“Exciting technological advances are revolutionizing urology. Prostate cancer is very common and current treatments can majorly impact a man's sexual and urinary function,” Dr. Sprenkle says. “Developing ways to minimize the impact of prostate cancer diagnosis and treatment on a man's health and quality of life is tremendously rewarding.”
Dr. Sprenkle believes in working with patients to come up with individualized treatment plans. “I want my patients to feel that I hear their concerns and treat them like a person. I am pleased at the end of a long consultation when they feel like they understand their disease and their options.”
Award | Awarding Organization | Date |
---|---|---|
2021 Thesis Reviewer, PA Master Thesis Committee, Yale School of Medicine | 2021 | |
Mentor Appreciation Award | Interprofessional Longitudinal Clinical Experience | 2017, 2018, 2019, 2020 |
Best Poster Podium Presentation | Young Urologic Oncologist dinner, Society Of Urologic Oncology Annual Meeting | 2009 |
Finalist - NY section AUA Valentine Essay Contest | NY Academy of Medicine | 2009 |
Finalist - NY section AUA Valentine Essay Contest | NY Academy of Medicine | 2007 |
First Prize - NY section AUA Valentine Essay Contest | NY Academy of Medicine | 2006 |
Arnold P. Gold Humanism in Medicine Honors Society | 2004 | |
Alpha Omega Alpha Medical School Honors Society | 2004 | |
Outstanding Member of Stanford Community | Stanford University | 1998 |
Member, Board of Directors | Stanford University Alumni Association | 1997 |
Organization | Role | Date |
---|---|---|
Clinical Advisory Board, Profound Medical | Board Member | 2022 - 2023 |
NCCN Prostate Cancer Early Detection Guideline Panel | Vice Chair | 2021 - Present |
Department of Urology Medical Student Thesis review committee | Member | 2021 - 2023 |
VHA National Surgery Office - Robotic Surgery Surgical Advisory Board | Member | 2021 - Present |
NIH | Ad Hoc reviewer for NIH Clinical Trials Genitourinary Steering Committee | 2019 |
Scientific Advisory Board, Boston Scientific Inc. | Scientific review and advice on urologic products | 2019 - Present |
MCIC LLC | Surgeon representative on multi-institutional meetings to improve clinical outcomes | 2018 - Present |
Department of Urology Executive Committee | Member | 2016 - Present |
Urologic Oncology | Reviewer | 2016 - Present |
Oncotarget | Reviewer | 2016 - Present |
Nature Scientific Reports | Reviewer | 2016 - Present |
Department of Urology Residency Promotion Committee | Member | 2015 - 2019 |
Yale Prostate SPORE kickoff meeting | Planning Committee | 2015 |
Yale Interdisciplinary Prostate Program | Interdisciplinary group focused on collaborative research and development of clinical programs in prostate cancer | 2015 - Present |
Yale Urology Prostate Cancer Screening Clinic | Participant | 2015 - Present |
Clinical Genitourinary Cancer | Reviewer | 2015 - Present |
PLOS One | Reviewer | 2015 - Present |
Frontiers | Associate Editor | 2015 - Present |
NCCN Prostate Cancer Early Detection Guideline Panel | Board Member | 2014 - 2021 |
Urologic Clinical Cost and Value Committee | Member | 2014 - 2016 |
Interventional Radiology Purchasing Committee | Expert Panel Member | 2014 - 2016 |
Society of Urologic Oncology | Member | 2009 - Present |
Journal of Urology | Reviewer | 2009 - Present |
Frontiers in Science | Reviewer | 2009 - Present |
Urology | Reviewer | 2009 - Present |
Washington Heights free prostate cancer education and screening clinic | Participant | 2008 |
American Association of Clinical Urologists | Member | 2006 - Present |